Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
01/2005
01/05/2005EP1492534A1 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors
01/05/2005DE10328036A1 New N-benzyl-anthranilic acid (hetero)arylamide derivatives and analogs, are tyrosine kinase KDR and FLT inhibitors and angiogenesis inhibitors, useful e.g. for treating tumors, psoriasis or restenosis
01/05/2005CN1561341A Hydrolysis of [R(R*, R*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxide
01/05/2005CN1561246A Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease
01/05/2005CN1560036A 4-hydroxylic pyridine and production process thereof
01/05/2005CN1183128C N-(heterocyclic)-benzene or pyridine sulphozmides as antithrombotic agents and anticoagulants
01/05/2005CN1183119C Arylpiperzines as metalloproteinase inhibiting agents (MMP) and their use
01/05/2005CN1183113C Tri-aryl acid derivatives as PPAR receptor ligands
01/05/2005CN1183112C PEG-inerferon conjugate
01/05/2005CN1183107C Alkynyl containing hydroxamic acid compounds as TACE inhibitors
01/04/2005US6838564 Substituted pyridine herbicides
01/04/2005US6838483 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
01/04/2005US6838472 Substituted urea retinoid agonists
01/04/2005US6838466 Compounds for the treatment of inflammatory disorders
01/04/2005US6838128 Comprises chiral, nonracemic gamma-lactone tail
01/04/2005US6837908 For dyeing hair; efficiency
01/04/2005CA2350854C 1,4-dihydropyridine derivatives and methods of producing the same
01/04/2005CA2218134C The preparation of carboxylic acid derivatives
01/04/2005CA2186015C Nicotinic acid derivatives and herbicides
12/2004
12/30/2004US20040267051 By reacting aldehydes or ketones with ammonia or primary/secondary amines in presence of hydrogen-donor and homogeneous transition metal/complex catalysts
12/30/2004US20040267025 Compounds for the treatment of metabolic disorders
12/30/2004US20040267021 Preparation of terpyridines
12/30/2004US20040267018 cobalt metal complexed with a bi or tridentate bi or tripyridine ligands; useful as electron-transfer mediators in dye-sensitized solar cells and related photoelectrochromic devices
12/30/2004US20040267012 5'-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
12/30/2004US20040266901 Novel photosensitive compound, photosensitive resin, and photosensitive composition
12/30/2004US20040266856 Biaryloxymethylarenecarboxylic acids as glycogen synthase activator
12/30/2004US20040266837 Method for producing 2-halogen-pyridine-carboxylic acid amides
12/30/2004US20040266835 Inhibitors against complex II of electron transport system
12/30/2004US20040266822 Secondary amines; tissue specificity; reduced side effects; cardiovascular diseases, diabetes, bronchial and urinary smooth muscle spasms, ischemia, anoxic nerve injury
12/30/2004US20040266818 Histone deacetylase inhibitors; antiproliferative agents; autoimmune, allergic and inflammatory diseases; central nervous system disorders; potency, bioavailability
12/30/2004US20040266784 Calcium channel inhibitors comprising benzhydril spaced from piperazine
12/30/2004US20040266782 Cyclic amine derivatives-CCR-3 receptor antagonists
12/30/2004US20040266774 Amide compounds
12/30/2004US20040266773 Such as 4-(3-methoxyphenyl)-5-methyl-6-(2-fluorobenzyl)-2-(N-(2-pyridyl)ethyl-N -methyl)ethyl-pyridazin-3-one; drugs/prodrugs for treatment of sex-hormone related conditions in men/women
12/30/2004US20040266764 Hydroxamic acid derivatives
12/30/2004US20040266738 Fungicidal phenoxyphenylhydrazine derivatives
12/30/2004US20040265991 Process for preparation of (s)-alpha-halomethylpyridine-methanol derivatives
12/30/2004US20040265633 complex which includes a carboxylic acid as an ancillary ligand and a metal selected from platinum group elements; useful as a phosphorescence dopant of an organic electroluminescent device due to its high luminosity in the range of the blue wavelengths
12/30/2004US20040265629 Organic luminescent compounds and methods of making and using same
12/30/2004US20040265382 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery
12/29/2004WO2004113394A2 Living radical polymerization initiator comprising a functional group capable of reacting with polypeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drugs obtained therefrom
12/29/2004WO2004113349A1 Process for preparing 3-aminothienopyridone derivatives
12/29/2004WO2004113341A2 Fungicidal triazolopyrimidines
12/29/2004WO2004113331A1 Novel compounds that modulate pparϝ type receptors, and use thereof in cosmetic or pharmaceutical compositions
12/29/2004WO2004113299A1 A method for producing 1, 3-dialkylpyridinium oligomers and related compounds using a solid support
12/29/2004WO2004113281A1 Tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them
12/29/2004WO2004113279A1 Inhibitors of matrix metalloproteinase
12/29/2004WO2004113273A1 Pesticidally active ketone and oxime derivatives
12/29/2004WO2004112729A2 Dual function compounds and uses thereof
12/29/2004WO2004112480A2 Triazolopyrimidines
12/29/2004WO2004092146A3 N- (((((1,3-thiazol-2-yl) amino) carbonyl) phenyl) sulfonyl) phenylalanine derivatives and related compounds for the treatment of diabetes
12/29/2004WO2004076412A3 Aminoheteroaryl compounds as protein kinase inhibitors
12/29/2004WO2004002940A8 Inhibitors of hcv ns5b polymerase
12/29/2004WO2002043648A3 Compounds active at the glucocorticoid receptor ii
12/29/2004EP1491532A1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetyloholine receptors
12/29/2004EP1490337A2 Pro-dyes containing compositions for dyeing keratinous fibers
12/29/2004EP1490317A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/29/2004EP1490064A1 Substituted pyridinones as modulators of p38 map kinase
12/29/2004EP1490062A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/29/2004EP1490043A2 Spirocyclic amides as cannabinoid receptor modulators
12/29/2004EP1414800B1 A novel synthesis for heteroarylamine compounds
12/29/2004EP1311265B1 Pharmaceutical compositions for treating neurological disorders
12/29/2004EP1226138B1 Fab i inhibitors
12/29/2004EP1117643B1 New crystal modification n of torasemide
12/29/2004EP0826671B1 Heterocyclic amide compounds and medicinal use of the same
12/29/2004CN1558934A Water-color ink
12/29/2004CN1558901A Crystalline hydrates of nicotinic acid anilide and benzoyl anilide derivatives
12/29/2004CN1558719A Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides
12/29/2004CN1182120C Hydroxypyridone methide azo dyes
12/29/2004CN1182119C Astalosin like anti-cancer compound , making process and usage thereof, and pharmaceutical compositions containing the same
12/29/2004CN1182118C Process for synthesizing 3-(2,5,6-trihalo pyridine-3-yl)-3-oxo- ethyl propionate from 2,5,6-tri halo-3-cyanopyridine
12/29/2004CN1182117C Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors
12/29/2004CN1182116C Mutilin derivatives and their use as antibacterials
12/29/2004CN1182109C ((Aminoiminomethyl) amino) alkanecarboxamides and their applications in therapy
12/29/2004CN1181817C NF-KB inhibitors containing phenylmethyl benzoquinone as active ingredient
12/29/2004CA2529154A1 Novel compounds that modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions
12/29/2004CA2528927A1 Process for preparing 3-aminothienopyridone derivatives
12/29/2004CA2528538A1 Dual function compounds and uses thereof
12/28/2004US6835832 Catalytic hydrogenation
12/28/2004US6835753 Administering to the patient for inhibiting Fc receptor binding of immunoglobulin a compound selected from aromatic, heteroaromatic, cyclic, bicyclic and an amino acid derivative or salt
12/28/2004US6835752 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient
12/28/2004US6835739 Benzamides and related inhibitors of factor Xa
12/28/2004US6835731 Chemokine receptor binding heterocyclic compounds
12/28/2004US6835495 Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials
12/28/2004US6835216 Chain-breaking antioxidants
12/28/2004CA2126072C Tri-substituted phenyl derivatives and processes for their preparation
12/23/2004WO2004111031A1 Pyridinyl carbamates as hormone-sensitive lipase inhibitors
12/23/2004WO2004111008A2 Use of a compound of formula i for making a pharmaceutical composition
12/23/2004WO2004111007A1 1-aryl-4-(aryloxycarbonyl)-piperazine derivatives for use as inhibitors of hormone sensitive lipase
12/23/2004WO2004111006A1 Para-subtituted phenyl carbamates as inhibitors of hormone sensitive lipase
12/23/2004WO2004111005A1 Anthranylamide pyridones that inhibit vegfr-2 and vegfr-3
12/23/2004WO2004111004A1 Substituted piperazine carbamates for use as inhibitors of hormone sensitive lipase
12/23/2004WO2004110986A1 Benzamide derivative or salt thereof
12/23/2004WO2004110983A2 New benzamides as pparϒ modulators
12/23/2004WO2004110442A1 Pyridine n-oxides as antiviral agents
12/23/2004WO2004110364A2 Thiotungstate analogues and uses thereof
12/23/2004WO2004099150A3 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands
12/23/2004WO2004091518A3 Cxcr4 chemokine receptor binding compounds
12/23/2004WO2004089904A3 Preparation of torasemide
12/23/2004WO2004087048A3 Benzamide modulators of metabotropic glutamate receptors